Back to User profile » Dr Ping-Hung Kuo
Papers published by Dr Ping-Hung Kuo:
Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study
Hsieh MJ, Chen NH, Cheng SL, Tao CW, Wei YF, Wu YK, Chan MC, Liu SF, Hsu WH, Yang TM, Lin MS, Liu CL, Kuo PH, Tsai YH
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:967-976
Published Date: 27 April 2022
The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study
Hsieh MJ, Huang SY, Yang TM, Tao CW, Cheng SL, Lee CH, Kuo PH, Wu YK, Chen NH, Hsu WH, Hsu JY, Lin MS, Wang CC, Wei YF, Tsai YH
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2949-2959
Published Date: 25 September 2018
Impact of overweight and obesity on acute exacerbations of COPD – subgroup analysis of the Taiwan Obstructive Lung Disease cohort
Wei YF, Tsai YH, Wang CC, Kuo PH
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2723-2729
Published Date: 12 September 2017
Wheezing, a significant clinical phenotype of COPD: experience from the Taiwan Obstructive Lung Disease Study
Huang WC, Tsai YH, Wei YF, Kuo PH, Tao CW, Cheng SL, Lee CH, Wu YK, Chen NH, Hsu WH, Hsu JY, Wang CC, Lin MS
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2121-2126
Published Date: 7 October 2015
Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD – subgroup analysis of the Taiwan obstructive lung disease cohort
Wei YF, Kuo PH, Tsai YH, Tao CW, Cheng SL, Lee CH, Wu YK, Chen NH, Hsu WH, Hsu JY, Lin MS, Wang CC
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1951-1956
Published Date: 14 September 2015